Healthcare - Biotechnology - NASDAQ - US
$ 26.91
2.95 %
$ 1.29 B
Market Cap
-19.5
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
18.92%
Net Income
Estimate
20.55%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Cassava Sciences, Inc.
SAVA has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart SAVA
EBIT FORECAST
EBIT Forecast Chart SAVA
NET INCOME FORECAST
Net Income Chart SAVA